Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Immuneering Corp changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 69 | 85 | +16 |
| Shares | 26.2M | 31.7M | +5.52M (+21.1%) |
| Value | $183.3M | $208.6M | +$25.3M (+13.8%) |
New holders (30)
Institutions that held Immuneering Corp at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (14)
Institutions that held Immuneering Corp at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| ExodusPoint Capital Management, LP | 1,516,833 | $10.6M |
| Logos Global Management LP | 950,000 | $6.65M |
| Monashee Investment Management LLC | 300,000 | $2.10M |
| Iridian Asset Management LLC | 275,086 | $1.93M |
| AWM Investment Company, Inc. | 150,000 | $1.05M |
| Avidity Partners Management LP | 90,900 | $636.3K |
| Royal Bank of Canada | 71,000 | $497.0K |
| XTX Topco Ltd | 64,040 | $448.3K |
| Ameriprise Financial Inc | 47,299 | $331.1K |
| Gsa Capital Partners LLP | 37,836 | $265.0K |
| CI Private Wealth, LLC | 36,090 | $252.6K |
| Quadrature Capital Ltd | 23,785 | $165.9K |
| Heights Capital Management, Inc | 20,000 | $140.0K |
| Virtu Financial LLC | 13,994 | $98.0K |